Cargando…
Venous Leg Ulcers: Advanced Therapies and New Technologies
The prevalence of venous leg ulcers (VLUs) differs between 1.5% and 3% in the general population. The challenge in treating VLUs is common recurrence. Moreover, VLUs can be resistant to healing, despite appropriate treatment. In these cases, advanced wound therapies should be considered. The number...
Autores principales: | Aleksandrowicz, Hubert, Owczarczyk-Saczonek, Agnieszka, Placek, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615583/ https://www.ncbi.nlm.nih.gov/pubmed/34829797 http://dx.doi.org/10.3390/biomedicines9111569 |
Ejemplares similares
-
Acneiform rash during lung cancer therapy with erlotinib (Tarceva(®))
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2013) -
Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
por: Kapała, Jan, et al.
Publicado: (2022) -
Psychological Stress, Mast Cells, and Psoriasis—Is There Any Relationship?
por: Woźniak, Ewelina, et al.
Publicado: (2021) -
The Role of T(RM) Cells in the Pathogenesis of Vitiligo—A Review of the Current State-Of-The-Art
por: Frączek, Alicja, et al.
Publicado: (2020) -
Tetracyclines—An Important Therapeutic Tool for Dermatologists
por: Orylska-Ratynska, Malgorzata, et al.
Publicado: (2022)